-
TAK-715: A Selective p38 MAPK Inhibitor Workflow
2026-08-23
TAK-715 combines nanomolar p38α selectivity with a practical workflow for dissecting cytokine responses, inflammatory signaling, and phosphorylation dynamics. This guide shows how to build reproducible cell-based assays, interpret dephosphorylation data, and troubleshoot common potency and endpoint problems.
-
UBR1 and UBR2: ER Stress Sensors in Mammals
2026-08-22
The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of protein quality control in mammalian cells. Its findings connect N-degron-mediated ubiquitination, proteasomal turnover, and survival during endoplasmic reticulum stress, while also defining important mechanistic questions for future ER-associated degradation research.
-
Milk-Derived Vesicle Uptake in Intestinal Organoids
2026-08-21
This reference study establishes three porcine intestinal stem cell–based models to examine milk-derived extracellular vesicle uptake in physiologically relevant epithelial architectures. Its central findings are that uptake depends on epithelial polarity and that colon-derived models show transcriptional responses associated with stemness and differentiation, while inhibitor experiments support an endocytic mechanism.
-
Nuclear mTORC1 Transcriptional Control by TerminaTOR
2026-08-20
The reference study introduces TerminaTOR, a genetically encodable inhibitor that can be directed to defined subcellular compartments to distinguish lysosomal from nuclear mTORC1 functions. By selectively perturbing nuclear mTORC1, the authors identify a noncanonical role in regulating transcription of CCAAT motif-containing genes, providing a framework for studying spatially organized nutrient signaling.
-
ACE2–Sirt1 Mitochondrial Biogenesis in Sepsis
2026-08-20
A February 2024 mouse study links sepsis-induced cardiomyopathy to reduced cardiac ACE2 signaling and impaired MasR–Sirt1-associated mitochondrial biogenesis. Its complementary use of an ACE2 activator and inhibitor connects this pathway with cardiac dysfunction, inflammation, oxidative stress, and cardiomyocyte apoptosis, while also highlighting important limits on pharmacological interpretation.
-
BKT140: CXCR4 Assay Logic for Cancer Research
2026-08-19
BKT140, also known as BL-8040, offers a powerful way to interrogate CXCR4 biology across tumor migration, apoptosis, and stem cell mobilization. This article presents an assay-interpretation framework that connects functional pharmacology with emerging CXCR4 imaging and theranostic research.
-
WSP-5 for Live-Cell H2S Imaging
2026-08-19
WSP-5, also called Washington State Probe-5, is a rapid turn-on fluorescent probe for visualizing changing hydrogen sulfide levels in living cells. This guide translates the diabetic cardiomyopathy literature into practical assay workflows, donor-release experiments, cancer model imaging, and troubleshooting strategies.
-
Galectin-1, FIP200, and Hepatic Steatosis
2026-08-18
The reference study identifies galectin-1 as an upstream inhibitor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance. Its central advance is the discovery of a direct Gal-1–FIP200 interaction that disrupts ULK-complex function, providing a mechanistic link between lectin signaling and metabolic liver disease.
-
Sex Differences in Angiotensin II Hypertension
2026-08-18
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II infusion produces a substantially larger pressor response in conscious male mice than in female mice, while gonadectomy reverses much of this pattern. By combining telemetry, endocrine manipulation, baroreflex testing, and ganglionic blockade, the study connected sex-dependent blood pressure responses with altered autonomic regulation.
-
Cy5-UTP RNA Labeling: Workflow and Troubleshooting
2026-08-17
Cy5-UTP enables direct, far-red visualization of RNA made by T7 in vitro transcription, supporting FISH, RNA localization studies, and dual-color expression arrays. This practical guide connects probe synthesis and imaging decisions with new insights into intracellular nanoparticle trafficking.
-
DiI (DiIC18(3)) Plasma Membrane Probe
2026-08-17
DiI (DiIC18(3)) provides orange-red membrane labeling for live or fixed cells and tissues, supporting neuronal tracing, migration, fusion, adhesion, and lipoprotein-labeling workflows. Because it is lipophilic, water-insoluble, and sensitive to permeabilization conditions, it should not be used as a water-only stain or a selective intracellular-organelle probe.
-
Iptacopan (LNP023) in Complement Assays
2026-08-16
This scenario-based guide explains how Iptacopan (LNP023), SKU C8699, can help researchers separate complement-mediated injury from intrinsic cellular toxicity. It covers assay compatibility, concentration selection, controls, interpretation of biochemical versus serum activity, and practical product-selection criteria.
-
Poly (I:C) Workflows for Innate Immune Assays
2026-08-15
Use Poly (I:C) to create a controlled dsRNA-like challenge for interferon studies, macrophage polarization assays, dendritic cell maturation, and selected hPSC-derived cardiomyocyte workflows. This guide translates a CXCL10-CXCR3-LAMP1 macrophage study into practical assay design, optimization, and troubleshooting decisions.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-08-15
Translate HMGB1 biomarker discovery into practical fluorescence, flow cytometry, and western blot validation workflows. This Cy3 secondary-antibody strategy adds signal amplification while preserving flexibility across mouse primary antibodies and orthogonal assay formats.
-
EGTA: Calcium Control in Endothelial Inflammation
2026-08-14
Discover how EGTA and egtazic acid can function as causal boundary-condition reagents in endothelial calcium signaling studies. This guide connects selective calcium chelation with the Piezo1–Talin1–YAP inflammation axis and provides assay-design controls beyond generic calcium depletion.
451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page